KLACID

This brand name is authorized in Australia, Austria, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey.

Active ingredients

The drug KLACID contains one active pharmaceutical ingredient (API):

1	Clarithromycin UNII H1250JIK0A - CLARITHROMYCIN
	Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.
	Read more about Clarithromycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KLACID Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA09	Clarithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8318T, 9192T
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00557576, 00776798, 01449133, 03873148, 03873154
EE	Ravimiamet	1032736, 1032747, 1032758, 1044177, 1068881, 1068904, 1405460, 1405471, 1405482, 1405493, 1405505, 1405516, 1405527, 1405538
ES	Centro de información online de medicamentos de la AEMPS	60202, 60515, 60518, 63380
FI	Lääkealan turvallisuus- ja kehittämiskeskus	134338, 135079, 494146, 582833
HK	Department of Health Drug Office	35866, 36468, 38143, 38306, 42378, 43890, 48787, 59109
IE	Health Products Regulatory Authority	16675, 30079, 31603, 31714, 32000, 32064, 32065, 92029, 92037, 92207
IL	מִשְׂרַד הַבְּרִיאוּת	2761
IT	Agenzia del Farmaco	027370055, 027370067, 027370117, 027370129, 027370143
LT	Valstybinė vaistų kontrolės tarnyba	1003065, 1003066, 1003067, 1003068, 1003316, 1009157, 1036969, 1060307, 1060308, 1060309, 1060310, 1060311, 1060312, 1060313, 1079071, 1081427, 1081951, 1090126, 1090127
MT	Medicines Authority	MA1507/01301, MA1507/01302, MA1507/01303, MA1507/01304, MA1507/01305, MA1507/01306, PI1438/02301A, PI1438/02302A, PI908/06402A, PI908/06405A
NL	Z-Index G-Standaard, PRK	49425
NZ	Medicines and Medical Devices Safety Authority	6457, 6458, 6459, 6460, 6464
PL	Rejestru Produktów Leczniczych	100033462, 100033479, 100075673, 100082294, 100082928, 100084873, 100332963, 100335890, 100370372, 100383370, 100419894, 100437136, 100451711, 100456970, 100463529
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68967001, W68967002, W68968001, W68969001, W68969002, W68970001, W68970002, W68970003
SG	Health Sciences Authority	07085P, 09119P, 09193P, 09354P, 09884P, 11387P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699548030802, 8699548030864, 8699548031601, 8699548090479, 8699548270482, 8699548280283, 8699548280511, 8699548281112
ZA	Health Products Regulatory Authority	28/20.1.1/0035, 31/20.1.1/0379